Patiromer Oral Product

DRUG2 trials

Sponsors

Wake Forest University Health Sciences, Oslo University Hospital

Conditions

End Stage Renal Failure on DialysisHyperkalemiaKidney Transplant

Phase 3

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease

CompletedNCT03740048

Wake Forest University Health SciencesEnd Stage Renal Failure on Dialysis

Start: 2019-06-19End: 2021-11-04Updated: 2023-06-09

Phase 4

Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients

CompletedNCT05029310

Oslo University HospitalHyperkalemia, Kidney Transplant

Start: 2021-09-01End: 2023-02-01Updated: 2023-03-23

Related Papers

Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis

BMC Nephrology2022-09-277 citations

Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.

2021-12-1826 citations

Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial

BMJ Open2021-05-0117 citations